equity and inclusion remain the missing links in canada’s clinical trials: 'this is a real challenge'
“the problem is that culturally, we as a society accept the incompleteness because it affects the marginalized groups. we don’t stand up and voice that concern for the marginalized group."
the future of clinical trials: bringing hybrid and decentralized methods to all canadians
the covid-19 pandemic brought unexpected change to the world of clinical trials, forcing the conductors of such studies to explore new and more flexible ways to perform medical research.
blood cancer treatment becomes first to benefit from canada's drug agency fast-track program
canada’s drug agency's time-limited recommendation program is set to deliver its first breakthrough with the blood cancer treatment epkinly.